249 results
Page 5 of 13
8-K
EX-99.1
il7 w2bybmzt
19 Jun 20
Rexahn and Ocuphire Enter into Definitive Merger Agreement
9:02am
8-K
EX-10.2
4jowh562m3iqeos
19 Jun 20
Rexahn and Ocuphire Enter into Definitive Merger Agreement
9:02am
8-K
EX-4.1
e4zvo
19 Jun 20
Rexahn and Ocuphire Enter into Definitive Merger Agreement
9:02am
8-K
EX-10.1
yhpiktt1q
19 Jun 20
Rexahn and Ocuphire Enter into Definitive Merger Agreement
9:02am
425
EX-2.1
ldof8
19 Jun 20
Business combination disclosure
9:00am
425
EX-10.1
c4ui5muozc uzh0xiz43
19 Jun 20
Business combination disclosure
9:00am
425
EX-99.1
yblh9vs
19 Jun 20
Business combination disclosure
9:00am
425
7xgrpa994lqiqey
19 Jun 20
Business combination disclosure
9:00am
425
EX-4.1
tcsjbwd3ty
19 Jun 20
Business combination disclosure
9:00am
425
EX-10.4
77k194
19 Jun 20
Business combination disclosure
9:00am
425
EX-4.2
1frz gh6ot5
19 Jun 20
Business combination disclosure
9:00am
425
EX-10.2
bkgm ulp3xmjdc
19 Jun 20
Business combination disclosure
9:00am
425
ahzrjdp
18 Jun 20
Business combination disclosure
9:14am
8-K
EX-99.1
i7wl78gkh
7 Aug 19
Rexahn Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Update on RX-3117 Development
6:43am
CORRESP
um2o6ag
26 Jul 19
Correspondence with SEC
12:00am
8-K
EX-99.1
yvv2einhaiijl1di4df
29 May 19
Rexahn Announces Move to Nasdaq
12:56pm
8-K
EX-99.1
4mu1h7e 05pe
16 Apr 19
Rexahn and BioSense Global Announce Collaboration and License Agreement for RX-3117 in Greater China
8:03am